NanoViricides raises $2M in registered direct offering of shares and warrants

NANOVIRICIDES, INC.

Offering of 1,333,334 shares (or pre-funded warrants) plus 1,333,334 warrants at $1.75, priced at $1.50 per share.
Gross proceeds $2,000,001; closed May 18, 2026; D. Boral Capital as placement agent.
Single institutional investor purchased entire offering; CEO agreed to 30-day lock-up.
Net proceeds to fund working capital, R&D, and clinical trial expenses.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

NANOVIRICIDES, INC. entered into Placement Agency Agreement with D. Boral Capital LLC (the "Placement Agent") (effective 2026-05-15).

Action: entry
Agreement: underwriting
Counterparty: D. Boral Capital LLC (the "Placement Agent")
Effective: 2026-05-15

Exact text from the filing

the Company entered into a Placement Agency Agreement with D. Boral Capital LLC (the "Placement Agent"), dated May 15, 2026, pursuant to which the Placement Agent acted as the exclusive placement agent for the Company in connection with the Offering (the "Placement Agency Agreement")

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

NANOVIRICIDES, INC. entered into Securities Purchase Agreement with a certain purchaser (the "Investor") valued at approximately $2.0 million (effective 2026-05-15).

Action: entry
Agreement: equity purchase
Counterparty: a certain purchaser (the "Investor")
Value: approximately $2.0 million
Effective: 2026-05-15

Exact text from the filing

On May 15, 2026, NanoViricides, Inc. (the "Company") and a certain purchaser (the "Investor") entered into a securities purchase agreement (the "Securities Purchase Agreement")

View on SEC.gov

Browse all material agreements →

NANOVIRICIDES, INC. filing history →

Source: SEC EDGAR

accession 0001104659-26-064544

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.